Search

Your search keyword '"Cornec D"' showing total 448 results
Start Over Author "Cornec D"
448 results on '"Cornec D"'

1. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

Author

Peh, C. Au, Chakera, A., Cooper, B., Kurtkoti, J., Langguth, D., Levidiotis, V., Luxton, G., Mount, P., Mudge, D., Noble, E., Phoon, R., Ranganathan, D., Ritchie, A., Ryan, J., Suranyi, M., Rosenkranz, A., Lhotta, K., Kronbichler, A., Demoulin, N., Bovy, C., Hellemans, R., Hougardy, J., Sprangers, B., Wissing, K., Pagnoux, C., Barbour, S., Brachemi, S., Cournoyer, S., Girard, L., Laurin, L., Liang, P., Philibert, D., Walsh, M., Tesar, V., Becvar, R., Horak, P., Rychlik, I., Szpirt, W., Dieperink, H., Gregersen, J., Ivarsen, P., Krarup, E., Lyngsoe, C., Rigothier, C., Augusto, J., Belot, A., Chauveau, D., Cornec, D., Jourde-Chiche, N., Ficheux, M., Karras, A., Klein, A., Maurier, F., Mesbah, R., Moranne, O., Neel, A., Quemeneur, T., Saadoun, D., Terrier, B., Zaoui, P., Schaier, M., Benck, U., Bergner, R., Busch, M., Floege, J., Grundmann, F., Haller, H., Haubitz, M., Hellmich, B., Henes, J., Hohenstein, B., Hugo, C., Iking-Konert, C., Arndt, F., Kubacki, T., Kotter, I., Lamprecht, P., Lindner, T., Halbritter, J., Mehling, H., Schönermarck, U., Venhoff, N., Vielhauer, V., Witzke, O., Szombati, I., Szucs, G., Garibotto, G., Alberici, F., Brunetta, E., Dagna, L., De Vita, S., Emmi, G., Gabrielli, A., Manenti, L., Pieruzzi, F., Roccatello, D., Salvarani, C., Dobashi, H., Atsumi, T., Fujimoto, S., Hagino, N., Ihata, A., Kaname, S., Kaneko, Y., Katagiri, A., Katayama, M., Kirino, Y., Kitagawa, K., Komatsuda, A., Kono, H., Kurasawa, T., Matsumura, R., Mimura, T., Morinobu, A., Murakawa, Y., Naniwa, T., Nanki, T., Ogawa, N., Oshima, H., Sada, K., Sugiyama, E., Takeuchi, T., Taki, H., Tamura, N., Tsukamoto, T., Yamagata, K., Yamamura, M., van Daele, P., Rutgers, A., Teng, Y., Walker, R., Chua, I., Collins, M., Rabindranath, K., de Zoysa, J., Svensson, M., Grevbo, B., Kalstad, S., Little, M., Clarkson, M., Molloy, E., Pamplona, I. Agraz, Anton, J., Lucia, V. Barrio, Ciggaran, S., Cid, M. Cinta, Encarnacion, M. Diaz, Oliveras, X. Fulladosa, Soler, M. Jose, Rusinol, H. Marco, Praga, M., Porras, L. Quintana, Segarra, A., Bruchfeld, A., Segelmark, M., Soveri, I., Thomaidi, E., Westman, K., Neumann, T., Burnier, M., Daikeler, T., Dudler, J., Hauser, T., Seeger, H., Vogt, B., Jayne, D., Burton, J., Al Jayyousi, R., Amin, T., Andrews, J., Baines, L., Brogan, P., Dasgupta, B., Doulton, T., Flossmann, O., Griffin, S., Harper, J., Harper, L., Kidder, D., Klocke, R., Lanyon, P., Luqmani, R., McLaren, J., Makanjuola, D., McCann, L., Nandagudi, A., Selvan, S., O'Riordan, E., Patel, M., Patel, R., Pusey, C., Rajakariar, R., Robson, J., Robson, M., Salama, A., Smyth, L., Sznajd, J., Taylor, J., Merkel, P., Sreih, A., Belilos, E., Bomback, A., Carlin, J., Chen Lin, Y. Chang, Derebail, V., Dragoi, S., Dua, A., Forbess, L., Geetha, D., Gipson, P., Gohh, R., Greenwood, G.T., Hugenberg, S., Jimenez, R., Kaskas, M., Kermani, T., Kivitz, A., Koening, C., Langford, C., Marder, G., Mohamed, A., Monach, P., Neyra, N., Niemer, G., Niles, J., Obi, R., Owens, C., Parks, D., Podoll, A., Rovin, B., Sam, R., Shergy, W., Silva, A., Specks, U., Spiera, R., Springer, J., Striebich, C., Swarup, A., Thakar, S., Tiliakos, A., Tsai, Y., Waguespack, D., Wasko, M. Chester, Cortazar, Frank B., Niles, John L., Jayne, David R.W., Merkel, Peter A., Bruchfeld, Annette, Yue, Huibin, Schall, Thomas J., and Bekker, Pirow

Published
2023
Full Text
View/download PDF

5. POS1258 STRATIFICATION OF SJÖGREN’S DISEASE, BASED ON SYMPTOMS, CLINICAL AND ROUTINE BIOLOGICAL DATA, IS SUPPORTED BY DISTINCT PATHOPHYSIOLOGICAL PATHWAYS

Author

Nguyen, Y., primary, Mariette, X., additional, Beydon, M., additional, Cornec, D., additional, Pers, J. O., additional, Morel, J., additional, Perdriger, A., additional, Dernis, E., additional, Devauchelle-Pensec, V., additional, Sene, D., additional, Dieudé, P., additional, Couderc, M., additional, Fauchais, A. L., additional, Larroche, C., additional, Vittecoq, O., additional, Salliot, C., additional, Hachulla, E., additional, Le Guern, V., additional, Gottenberg, J. E., additional, Seror, R., additional, and Nocturne, G., additional

Published
2024
Full Text
View/download PDF

7. OP0194 COMPUTATIONAL SYSTEMS BIOLOGY APPROACH TO UNVEIL MOLECULAR INTERACTIONS IN SJÖGREN’S SYNDROME PATHOGENESIS

Author

Silva-Saffar, S. E, primary, Gottenberg, J. E., additional, Bombardieri, M., additional, Cornec, D., additional, Pers, J. O., additional, Alarcon-Riquelme, M., additional, Moingeon, P., additional, Barnes, M., additional, Ng, S., additional, Ng, W. F., additional, Mariette, X., additional, Nocturne, G., additional, and Niarakis, A., additional

Published
2024
Full Text
View/download PDF

8. OP0207 NATIONWIDE EPIDEMIOLOGY OF LYMPHOPROLIFERATIVE DISORDERS COMPLICATING SJÖGREN DISEASE (SD): DATA ON 46,012 PATIENTS WITH SD AND 1749 LYMPHOMAS FROM THE FRENCH HEALTHCARE INFORMATION SYSTEM

Author

Gottenberg, J. E., primary, Duret, P. M., additional, Yamdjieu Ngadeu, C., additional, Sauleau, E., additional, Meyer, N., additional, Cornec, D., additional, Saraux, A., additional, Devauchelle-Pensec, V., additional, Sibilia, J., additional, Nocturne, G., additional, Mariette, X., additional, and Seror, R., additional

Published
2024
Full Text
View/download PDF

9. OP0261 ASSESSMENT OF THE REMISSION MAINTENANCE AFTER TOCILIZUMAB WITHDRAWAL IN POLYMYALGIA RHEUMATICA PATIENTS RECEIVING A 6-MONTH TREATMENT

Author

Chevet, B., primary, Aghiles, S., additional, Emmanuel, N., additional, Carvajal Alegria, G., additional, Dernis, E., additional, Richez, C., additional, Truchetet, M. E., additional, Wendling, D., additional, Toussirot, E., additional, Perdriger, A., additional, Gottenberg, J. E., additional, Felten, R., additional, Fautrel, B., additional, Lohse, A., additional, Chiche, L., additional, Hilliquin, P., additional, Le Henaff Bourhis, C., additional, Benjamin, D., additional, Direz, G., additional, Chary-Valckenaere, I., additional, Cornec, D., additional, Guellec, D., additional, Marhadour, T., additional, Saraux, A., additional, and Devauchelle-Pensec, V., additional

Published
2024
Full Text
View/download PDF

13. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

Author

Cortazar, F. B., Niles, J. L., Jayne, D. R. W., Merkel, P. A., Bruchfeld, A., Yue, H., Schall, T. J., Bekker, P., Peh, C. A., Chakera, A., Cooper, B., Kurtkoti, J., Langguth, D., Levidiotis, V., Luxton, G., Mount, P., Mudge, D., Noble, E., Phoon, R., Ranganathan, D., Ritchie, A., Ryan, J., Suranyi, M., Rosenkranz, A., Lhotta, K., Kronbichler, A., Demoulin, N., Bovy, C., Hellemans, R., Hougardy, J., Sprangers, B., Wissing, K., Pagnoux, C., Barbour, S., Brachemi, S., Cournoyer, S., Girard, L., Laurin, L., Liang, P., Philibert, D., Walsh, M., Tesar, V., Becvar, R., Horak, P., Rychlik, I., Szpirt, W., Dieperink, H., Gregersen, J., Ivarsen, P., Krarup, E., Lyngsoe, C., Rigothier, C., Augusto, J., Belot, A., Chauveau, D., Cornec, D., Jourde-Chiche, N., Ficheux, M., Karras, A., Klein, A., Maurier, F., Mesbah, R., Moranne, O., Neel, A., Quemeneur, T., Saadoun, D., Terrier, B., Zaoui, P., Schaier, M., Benck, U., Bergner, R., Busch, M., Floege, J., Grundmann, F., Haller, H., Haubitz, M., Hellmich, B., Henes, J., Hohenstein, B., Hugo, C., Iking-Konert, C., Arndt, F., Kubacki, T., Kotter, I., Lamprecht, P., Lindner, T., Halbritter, J., Mehling, H., Schonermarck, U., Venhoff, N., Vielhauer, V., Witzke, O., Szombati, I., Szucs, G., Garibotto, G., Alberici, F., Brunetta, E., Dagna, L., De Vita, S., Emmi, G., Gabrielli, A., Manenti, L., Pieruzzi, F., Roccatello, D., Salvarani, C., Dobashi, H., Atsumi, T., Fujimoto, S., Hagino, N., Ihata, A., Kaname, S., Kaneko, Y., Katagiri, A., Katayama, M., Kirino, Y., Kitagawa, K., Komatsuda, A., Kono, H., Kurasawa, T., Matsumura, R., Mimura, T., Morinobu, A., Murakawa, Y., Naniwa, T., Nanki, T., Ogawa, N., Oshima, H., Sada, K., Sugiyama, E., Takeuchi, T., Taki, H., Tamura, N., Tsukamoto, T., Yamagata, K., Yamamura, M., van Daele, P., Rutgers, A., Teng, Y., Walker, R., Chua, I., Collins, M., Rabindranath, K., de Zoysa, J., Svensson, M., Grevbo, B., Kalstad, S., Little, M., Clarkson, M., Molloy, E., Pamplona, I. A., Anton, J., Lucia, V. B., Ciggaran, S., Cid, M. C., Encarnacion, M. D., Oliveras, X. F., Soler, M. J., Rusinol, H. M., Praga, M., Porras, L. Q., Segarra, A., Segelmark, M., Soveri, I., Thomaidi, E., Westman, K., Neumann, T., Burnier, M., Daikeler, T., Dudler, J., Hauser, T., Seeger, H., Vogt, B., Jayne, D., Burton, J., Al Jayyousi, R., Amin, T., Andrews, J., Baines, L., Brogan, P., Dasgupta, B., Doulton, T., Flossmann, O., Griffin, S., Harper, J., Harper, L., Kidder, D., Klocke, R., Lanyon, P., Luqmani, R., Mclaren, J., Makanjuola, D., Mccann, L., Nandagudi, A., Selvan, S., O'Riordan, E., Patel, M., Patel, R., Pusey, C., Rajakariar, R., Robson, J., Robson, M., Salama, A., Smyth, L., Sznajd, J., Taylor, J., Merkel, P., Sreih, A., Belilos, E., Bomback, A., Carlin, J., Chen Lin, Y. C., Derebail, V., Dragoi, S., Dua, A., Forbess, L., Geetha, D., Gipson, P., Gohh, R., Greenwood, G. T., Hugenberg, S., Jimenez, R., Kaskas, M., Kermani, T., Kivitz, A., Koening, C., Langford, C., Marder, G., Mohamed, A., Monach, P., Neyra, N., Niemer, G., Niles, J., Obi, R., Owens, C., Parks, D., Podoll, A., Rovin, B., Sam, R., Shergy, W., Silva, A., Specks, U., Spiera, R., Springer, J., Striebich, C., Swarup, A., Thakar, S., Tiliakos, A., Tsai, Y., Waguespack, D., Wasko, M. C., Cortazar, F, Niles, J, Jayne, D, Merkel, P, Bruchfeld, A, Yue, H, Schall, T, Bekker, P, Peh, C, Chakera, A, Cooper, B, Kurtkoti, J, Langguth, D, Levidiotis, V, Luxton, G, Mount, P, Mudge, D, Noble, E, Phoon, R, Ranganathan, D, Ritchie, A, Ryan, J, Suranyi, M, Rosenkranz, A, Lhotta, K, Kronbichler, A, Demoulin, N, Bovy, C, Hellemans, R, Hougardy, J, Sprangers, B, Wissing, K, Pagnoux, C, Barbour, S, Brachemi, S, Cournoyer, S, Girard, L, Laurin, L, Liang, P, Philibert, D, Walsh, M, Tesar, V, Becvar, R, Horak, P, Rychlik, I, Szpirt, W, Dieperink, H, Gregersen, J, Ivarsen, P, Krarup, E, Lyngsoe, C, Rigothier, C, Augusto, J, Belot, A, Chauveau, D, Cornec, D, Jourde-Chiche, N, Ficheux, M, Karras, A, Klein, A, Maurier, F, Mesbah, R, Moranne, O, Neel, A, Quemeneur, T, Saadoun, D, Terrier, B, Zaoui, P, Schaier, M, Benck, U, Bergner, R, Busch, M, Floege, J, Grundmann, F, Haller, H, Haubitz, M, Hellmich, B, Henes, J, Hohenstein, B, Hugo, C, Iking-Konert, C, Arndt, F, Kubacki, T, Kotter, I, Lamprecht, P, Lindner, T, Halbritter, J, Mehling, H, Schonermarck, U, Venhoff, N, Vielhauer, V, Witzke, O, Szombati, I, Szucs, G, Garibotto, G, Alberici, F, Brunetta, E, Dagna, L, De Vita, S, Emmi, G, Gabrielli, A, Manenti, L, Pieruzzi, F, Roccatello, D, Salvarani, C, Dobashi, H, Atsumi, T, Fujimoto, S, Hagino, N, Ihata, A, Kaname, S, Kaneko, Y, Katagiri, A, Katayama, M, Kirino, Y, Kitagawa, K, Komatsuda, A, Kono, H, Kurasawa, T, Matsumura, R, Mimura, T, Morinobu, A, Murakawa, Y, Naniwa, T, Nanki, T, Ogawa, N, Oshima, H, Sada, K, Sugiyama, E, Takeuchi, T, Taki, H, Tamura, N, Tsukamoto, T, Yamagata, K, Yamamura, M, van Daele, P, Rutgers, A, Teng, Y, Walker, R, Chua, I, Collins, M, Rabindranath, K, de Zoysa, J, Svensson, M, Grevbo, B, Kalstad, S, Little, M, Clarkson, M, Molloy, E, Pamplona, I, Anton, J, Lucia, V, Ciggaran, S, Cid, M, Encarnacion, M, Oliveras, X, Soler, M, Rusinol, H, Praga, M, Porras, L, Segarra, A, Segelmark, M, Soveri, I, Thomaidi, E, Westman, K, Neumann, T, Burnier, M, Daikeler, T, Dudler, J, Hauser, T, Seeger, H, Vogt, B, Burton, J, Al Jayyousi, R, Amin, T, Andrews, J, Baines, L, Brogan, P, Dasgupta, B, Doulton, T, Flossmann, O, Griffin, S, Harper, J, Harper, L, Kidder, D, Klocke, R, Lanyon, P, Luqmani, R, Mclaren, J, Makanjuola, D, Mccann, L, Nandagudi, A, Selvan, S, O'Riordan, E, Patel, M, Patel, R, Pusey, C, Rajakariar, R, Robson, J, Robson, M, Salama, A, Smyth, L, Sznajd, J, Taylor, J, Sreih, A, Belilos, E, Bomback, A, Carlin, J, Chen Lin, Y, Derebail, V, Dragoi, S, Dua, A, Forbess, L, Geetha, D, Gipson, P, Gohh, R, Greenwood, G, Hugenberg, S, Jimenez, R, Kaskas, M, Kermani, T, Kivitz, A, Koening, C, Langford, C, Marder, G, Mohamed, A, Monach, P, Neyra, N, Niemer, G, Obi, R, Owens, C, Parks, D, Podoll, A, Rovin, B, Sam, R, Shergy, W, Silva, A, Specks, U, Spiera, R, Springer, J, Striebich, C, Swarup, A, Thakar, S, Tiliakos, A, Tsai, Y, Waguespack, D, and Wasko, M

Subjects
avacopan, Clinical Research, renal recovery, Nephrology, low eGFR, complement 5a receptor, complement, ANCA-associated vasculiti
Abstract

INTRODUCTION: In the 330-patient ADVOCATE trial of avacopan for the treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, in which 81% of patients had renal involvement, estimated glomerular filtration rate (eGFR) increased on average 7.3 ml/min per 1.73 m(2) in the avacopan group and 4.1 ml/min per 1.73 m(2) in the prednisone group (P = 0.029) at week 52. This new analysis examines the results in the patient subgroup with severe renal insufficiency at enrollment into the trial, i.e., eGFR ≤20 ml/min per 1.73 m(2). METHODS: eGFR was determined at baseline and over the course of the trial. Changes in eGFR were compared between the 2 treatment groups. RESULTS: In ADVOCATE, 27 of 166 patients (16%) in the avacopan group and 23 of 164 patients (14%) in the prednisone group had a baseline eGFR ≤20 ml/min per 1.73 m(2). At week 52, eGFR increased on average 16.1 and 7.7 ml/min per 1.73 m(2) in the avacopan and prednisone groups, respectively (P = 0.003). The last eGFR value measured during the 52-week treatment period was ≥2-fold higher than baseline in 41% of patients in the avacopan group compared to 13% in the prednisone group (P = 0.030). More patients in the avacopan group versus prednisone group had increases in eGFR above 20, 30, and 45 ml/min per 1.73 m(2), respectively. Serious adverse events occurred in 13 of 27 patients (48%) in the avacopan group and 16 of 23 patients (70%) in the prednisone group. CONCLUSION: Among patients with baseline eGFR ≤20 ml/min per 1.73 m(2) in the ADVOCATE trial, eGFR improved more in the avacopan group than in the prednisone group.

Published
2023
Full Text
View/download PDF

14. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

Author

Cortazar, F, Niles, J, Jayne, D, Merkel, P, Bruchfeld, A, Yue, H, Schall, T, Bekker, P, Peh, C, Chakera, A, Cooper, B, Kurtkoti, J, Langguth, D, Levidiotis, V, Luxton, G, Mount, P, Mudge, D, Noble, E, Phoon, R, Ranganathan, D, Ritchie, A, Ryan, J, Suranyi, M, Rosenkranz, A, Lhotta, K, Kronbichler, A, Demoulin, N, Bovy, C, Hellemans, R, Hougardy, J, Sprangers, B, Wissing, K, Pagnoux, C, Barbour, S, Brachemi, S, Cournoyer, S, Girard, L, Laurin, L, Liang, P, Philibert, D, Walsh, M, Tesar, V, Becvar, R, Horak, P, Rychlik, I, Szpirt, W, Dieperink, H, Gregersen, J, Ivarsen, P, Krarup, E, Lyngsoe, C, Rigothier, C, Augusto, J, Belot, A, Chauveau, D, Cornec, D, Jourde-Chiche, N, Ficheux, M, Karras, A, Klein, A, Maurier, F, Mesbah, R, Moranne, O, Neel, A, Quemeneur, T, Saadoun, D, Terrier, B, Zaoui, P, Schaier, M, Benck, U, Bergner, R, Busch, M, Floege, J, Grundmann, F, Haller, H, Haubitz, M, Hellmich, B, Henes, J, Hohenstein, B, Hugo, C, Iking-Konert, C, Arndt, F, Kubacki, T, Kotter, I, Lamprecht, P, Lindner, T, Halbritter, J, Mehling, H, Schonermarck, U, Venhoff, N, Vielhauer, V, Witzke, O, Szombati, I, Szucs, G, Garibotto, G, Alberici, F, Brunetta, E, Dagna, L, De Vita, S, Emmi, G, Gabrielli, A, Manenti, L, Pieruzzi, F, Roccatello, D, Salvarani, C, Dobashi, H, Atsumi, T, Fujimoto, S, Hagino, N, Ihata, A, Kaname, S, Kaneko, Y, Katagiri, A, Katayama, M, Kirino, Y, Kitagawa, K, Komatsuda, A, Kono, H, Kurasawa, T, Matsumura, R, Mimura, T, Morinobu, A, Murakawa, Y, Naniwa, T, Nanki, T, Ogawa, N, Oshima, H, Sada, K, Sugiyama, E, Takeuchi, T, Taki, H, Tamura, N, Tsukamoto, T, Yamagata, K, Yamamura, M, van Daele, P, Rutgers, A, Teng, Y, Walker, R, Chua, I, Collins, M, Rabindranath, K, de Zoysa, J, Svensson, M, Grevbo, B, Kalstad, S, Little, M, Clarkson, M, Molloy, E, Pamplona, I, Anton, J, Lucia, V, Ciggaran, S, Cid, M, Encarnacion, M, Oliveras, X, Soler, M, Rusinol, H, Praga, M, Porras, L, Segarra, A, Segelmark, M, Soveri, I, Thomaidi, E, Westman, K, Neumann, T, Burnier, M, Daikeler, T, Dudler, J, Hauser, T, Seeger, H, Vogt, B, Burton, J, Al Jayyousi, R, Amin, T, Andrews, J, Baines, L, Brogan, P, Dasgupta, B, Doulton, T, Flossmann, O, Griffin, S, Harper, J, Harper, L, Kidder, D, Klocke, R, Lanyon, P, Luqmani, R, Mclaren, J, Makanjuola, D, Mccann, L, Nandagudi, A, Selvan, S, O'Riordan, E, Patel, M, Patel, R, Pusey, C, Rajakariar, R, Robson, J, Robson, M, Salama, A, Smyth, L, Sznajd, J, Taylor, J, Sreih, A, Belilos, E, Bomback, A, Carlin, J, Chen Lin, Y, Derebail, V, Dragoi, S, Dua, A, Forbess, L, Geetha, D, Gipson, P, Gohh, R, Greenwood, G, Hugenberg, S, Jimenez, R, Kaskas, M, Kermani, T, Kivitz, A, Koening, C, Langford, C, Marder, G, Mohamed, A, Monach, P, Neyra, N, Niemer, G, Obi, R, Owens, C, Parks, D, Podoll, A, Rovin, B, Sam, R, Shergy, W, Silva, A, Specks, U, Spiera, R, Springer, J, Striebich, C, Swarup, A, Thakar, S, Tiliakos, A, Tsai, Y, Waguespack, D, Wasko, M, Cortazar F. B., Niles J. L., Jayne D. R. W., Merkel P. A., Bruchfeld A., Yue H., Schall T. J., Bekker P., Peh C. A., Chakera A., Cooper B., Kurtkoti J., Langguth D., Levidiotis V., Luxton G., Mount P., Mudge D., Noble E., Phoon R., Ranganathan D., Ritchie A., Ryan J., Suranyi M., Rosenkranz A., Lhotta K., Kronbichler A., Demoulin N., Bovy C., Hellemans R., Hougardy J., Sprangers B., Wissing K., Pagnoux C., Barbour S., Brachemi S., Cournoyer S., Girard L., Laurin L., Liang P., Philibert D., Walsh M., Tesar V., Becvar R., Horak P., Rychlik I., Szpirt W., Dieperink H., Gregersen J., Ivarsen P., Krarup E., Lyngsoe C., Rigothier C., Augusto J., Belot A., Chauveau D., Cornec D., Jourde-Chiche N., Ficheux M., Karras A., Klein A., Maurier F., Mesbah R., Moranne O., Neel A., Quemeneur T., Saadoun D., Terrier B., Zaoui P., Schaier M., Benck U., Bergner R., Busch M., Floege J., Grundmann F., Haller H., Haubitz M., Hellmich B., Henes J., Hohenstein B., Hugo C., Iking-Konert C., Arndt F., Kubacki T., Kotter I., Lamprecht P., Lindner T., Halbritter J., Mehling H., Schonermarck U., Venhoff N., Vielhauer V., Witzke O., Szombati I., Szucs G., Garibotto G., Alberici F., Brunetta E., Dagna L., De Vita S., Emmi G., Gabrielli A., Manenti L., Pieruzzi F., Roccatello D., Salvarani C., Dobashi H., Atsumi T., Fujimoto S., Hagino N., Ihata A., Kaname S., Kaneko Y., Katagiri A., Katayama M., Kirino Y., Kitagawa K., Komatsuda A., Kono H., Kurasawa T., Matsumura R., Mimura T., Morinobu A., Murakawa Y., Naniwa T., Nanki T., Ogawa N., Oshima H., Sada K., Sugiyama E., Takeuchi T., Taki H., Tamura N., Tsukamoto T., Yamagata K., Yamamura M., van Daele P., Rutgers A., Teng Y., Walker R., Chua I., Collins M., Rabindranath K., de Zoysa J., Svensson M., Grevbo B., Kalstad S., Little M., Clarkson M., Molloy E., Pamplona I. A., Anton J., Lucia V. B., Ciggaran S., Cid M. C., Encarnacion M. D., Oliveras X. F., Soler M. J., Rusinol H. M., Praga M., Porras L. Q., Segarra A., Segelmark M., Soveri I., Thomaidi E., Westman K., Neumann T., Burnier M., Daikeler T., Dudler J., Hauser T., Seeger H., Vogt B., Jayne D., Burton J., Al Jayyousi R., Amin T., Andrews J., Baines L., Brogan P., Dasgupta B., Doulton T., Flossmann O., Griffin S., Harper J., Harper L., Kidder D., Klocke R., Lanyon P., Luqmani R., McLaren J., Makanjuola D., McCann L., Nandagudi A., Selvan S., O'Riordan E., Patel M., Patel R., Pusey C., Rajakariar R., Robson J., Robson M., Salama A., Smyth L., Sznajd J., Taylor J., Merkel P., Sreih A., Belilos E., Bomback A., Carlin J., Chen Lin Y. C., Derebail V., Dragoi S., Dua A., Forbess L., Geetha D., Gipson P., Gohh R., Greenwood G. T., Hugenberg S., Jimenez R., Kaskas M., Kermani T., Kivitz A., Koening C., Langford C., Marder G., Mohamed A., Monach P., Neyra N., Niemer G., Niles J., Obi R., Owens C., Parks D., Podoll A., Rovin B., Sam R., Shergy W., Silva A., Specks U., Spiera R., Springer J., Striebich C., Swarup A., Thakar S., Tiliakos A., Tsai Y., Waguespack D., Wasko M. C., Cortazar, F, Niles, J, Jayne, D, Merkel, P, Bruchfeld, A, Yue, H, Schall, T, Bekker, P, Peh, C, Chakera, A, Cooper, B, Kurtkoti, J, Langguth, D, Levidiotis, V, Luxton, G, Mount, P, Mudge, D, Noble, E, Phoon, R, Ranganathan, D, Ritchie, A, Ryan, J, Suranyi, M, Rosenkranz, A, Lhotta, K, Kronbichler, A, Demoulin, N, Bovy, C, Hellemans, R, Hougardy, J, Sprangers, B, Wissing, K, Pagnoux, C, Barbour, S, Brachemi, S, Cournoyer, S, Girard, L, Laurin, L, Liang, P, Philibert, D, Walsh, M, Tesar, V, Becvar, R, Horak, P, Rychlik, I, Szpirt, W, Dieperink, H, Gregersen, J, Ivarsen, P, Krarup, E, Lyngsoe, C, Rigothier, C, Augusto, J, Belot, A, Chauveau, D, Cornec, D, Jourde-Chiche, N, Ficheux, M, Karras, A, Klein, A, Maurier, F, Mesbah, R, Moranne, O, Neel, A, Quemeneur, T, Saadoun, D, Terrier, B, Zaoui, P, Schaier, M, Benck, U, Bergner, R, Busch, M, Floege, J, Grundmann, F, Haller, H, Haubitz, M, Hellmich, B, Henes, J, Hohenstein, B, Hugo, C, Iking-Konert, C, Arndt, F, Kubacki, T, Kotter, I, Lamprecht, P, Lindner, T, Halbritter, J, Mehling, H, Schonermarck, U, Venhoff, N, Vielhauer, V, Witzke, O, Szombati, I, Szucs, G, Garibotto, G, Alberici, F, Brunetta, E, Dagna, L, De Vita, S, Emmi, G, Gabrielli, A, Manenti, L, Pieruzzi, F, Roccatello, D, Salvarani, C, Dobashi, H, Atsumi, T, Fujimoto, S, Hagino, N, Ihata, A, Kaname, S, Kaneko, Y, Katagiri, A, Katayama, M, Kirino, Y, Kitagawa, K, Komatsuda, A, Kono, H, Kurasawa, T, Matsumura, R, Mimura, T, Morinobu, A, Murakawa, Y, Naniwa, T, Nanki, T, Ogawa, N, Oshima, H, Sada, K, Sugiyama, E, Takeuchi, T, Taki, H, Tamura, N, Tsukamoto, T, Yamagata, K, Yamamura, M, van Daele, P, Rutgers, A, Teng, Y, Walker, R, Chua, I, Collins, M, Rabindranath, K, de Zoysa, J, Svensson, M, Grevbo, B, Kalstad, S, Little, M, Clarkson, M, Molloy, E, Pamplona, I, Anton, J, Lucia, V, Ciggaran, S, Cid, M, Encarnacion, M, Oliveras, X, Soler, M, Rusinol, H, Praga, M, Porras, L, Segarra, A, Segelmark, M, Soveri, I, Thomaidi, E, Westman, K, Neumann, T, Burnier, M, Daikeler, T, Dudler, J, Hauser, T, Seeger, H, Vogt, B, Burton, J, Al Jayyousi, R, Amin, T, Andrews, J, Baines, L, Brogan, P, Dasgupta, B, Doulton, T, Flossmann, O, Griffin, S, Harper, J, Harper, L, Kidder, D, Klocke, R, Lanyon, P, Luqmani, R, Mclaren, J, Makanjuola, D, Mccann, L, Nandagudi, A, Selvan, S, O'Riordan, E, Patel, M, Patel, R, Pusey, C, Rajakariar, R, Robson, J, Robson, M, Salama, A, Smyth, L, Sznajd, J, Taylor, J, Sreih, A, Belilos, E, Bomback, A, Carlin, J, Chen Lin, Y, Derebail, V, Dragoi, S, Dua, A, Forbess, L, Geetha, D, Gipson, P, Gohh, R, Greenwood, G, Hugenberg, S, Jimenez, R, Kaskas, M, Kermani, T, Kivitz, A, Koening, C, Langford, C, Marder, G, Mohamed, A, Monach, P, Neyra, N, Niemer, G, Obi, R, Owens, C, Parks, D, Podoll, A, Rovin, B, Sam, R, Shergy, W, Silva, A, Specks, U, Spiera, R, Springer, J, Striebich, C, Swarup, A, Thakar, S, Tiliakos, A, Tsai, Y, Waguespack, D, Wasko, M, Cortazar F. B., Niles J. L., Jayne D. R. W., Merkel P. A., Bruchfeld A., Yue H., Schall T. J., Bekker P., Peh C. A., Chakera A., Cooper B., Kurtkoti J., Langguth D., Levidiotis V., Luxton G., Mount P., Mudge D., Noble E., Phoon R., Ranganathan D., Ritchie A., Ryan J., Suranyi M., Rosenkranz A., Lhotta K., Kronbichler A., Demoulin N., Bovy C., Hellemans R., Hougardy J., Sprangers B., Wissing K., Pagnoux C., Barbour S., Brachemi S., Cournoyer S., Girard L., Laurin L., Liang P., Philibert D., Walsh M., Tesar V., Becvar R., Horak P., Rychlik I., Szpirt W., Dieperink H., Gregersen J., Ivarsen P., Krarup E., Lyngsoe C., Rigothier C., Augusto J., Belot A., Chauveau D., Cornec D., Jourde-Chiche N., Ficheux M., Karras A., Klein A., Maurier F., Mesbah R., Moranne O., Neel A., Quemeneur T., Saadoun D., Terrier B., Zaoui P., Schaier M., Benck U., Bergner R., Busch M., Floege J., Grundmann F., Haller H., Haubitz M., Hellmich B., Henes J., Hohenstein B., Hugo C., Iking-Konert C., Arndt F., Kubacki T., Kotter I., Lamprecht P., Lindner T., Halbritter J., Mehling H., Schonermarck U., Venhoff N., Vielhauer V., Witzke O., Szombati I., Szucs G., Garibotto G., Alberici F., Brunetta E., Dagna L., De Vita S., Emmi G., Gabrielli A., Manenti L., Pieruzzi F., Roccatello D., Salvarani C., Dobashi H., Atsumi T., Fujimoto S., Hagino N., Ihata A., Kaname S., Kaneko Y., Katagiri A., Katayama M., Kirino Y., Kitagawa K., Komatsuda A., Kono H., Kurasawa T., Matsumura R., Mimura T., Morinobu A., Murakawa Y., Naniwa T., Nanki T., Ogawa N., Oshima H., Sada K., Sugiyama E., Takeuchi T., Taki H., Tamura N., Tsukamoto T., Yamagata K., Yamamura M., van Daele P., Rutgers A., Teng Y., Walker R., Chua I., Collins M., Rabindranath K., de Zoysa J., Svensson M., Grevbo B., Kalstad S., Little M., Clarkson M., Molloy E., Pamplona I. A., Anton J., Lucia V. B., Ciggaran S., Cid M. C., Encarnacion M. D., Oliveras X. F., Soler M. J., Rusinol H. M., Praga M., Porras L. Q., Segarra A., Segelmark M., Soveri I., Thomaidi E., Westman K., Neumann T., Burnier M., Daikeler T., Dudler J., Hauser T., Seeger H., Vogt B., Jayne D., Burton J., Al Jayyousi R., Amin T., Andrews J., Baines L., Brogan P., Dasgupta B., Doulton T., Flossmann O., Griffin S., Harper J., Harper L., Kidder D., Klocke R., Lanyon P., Luqmani R., McLaren J., Makanjuola D., McCann L., Nandagudi A., Selvan S., O'Riordan E., Patel M., Patel R., Pusey C., Rajakariar R., Robson J., Robson M., Salama A., Smyth L., Sznajd J., Taylor J., Merkel P., Sreih A., Belilos E., Bomback A., Carlin J., Chen Lin Y. C., Derebail V., Dragoi S., Dua A., Forbess L., Geetha D., Gipson P., Gohh R., Greenwood G. T., Hugenberg S., Jimenez R., Kaskas M., Kermani T., Kivitz A., Koening C., Langford C., Marder G., Mohamed A., Monach P., Neyra N., Niemer G., Niles J., Obi R., Owens C., Parks D., Podoll A., Rovin B., Sam R., Shergy W., Silva A., Specks U., Spiera R., Springer J., Striebich C., Swarup A., Thakar S., Tiliakos A., Tsai Y., Waguespack D., and Wasko M. C.

Abstract

Introduction: In the 330-patient ADVOCATE trial of avacopan for the treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, in which 81% of patients had renal involvement, estimated glomerular filtration rate (eGFR) increased on average 7.3 ml/min per 1.73 m2 in the avacopan group and 4.1 ml/min per 1.73 m2 in the prednisone group (P = 0.029) at week 52. This new analysis examines the results in the patient subgroup with severe renal insufficiency at enrollment into the trial, i.e., eGFR ≤20 ml/min per 1.73 m2. Methods: eGFR was determined at baseline and over the course of the trial. Changes in eGFR were compared between the 2 treatment groups. Results: In ADVOCATE, 27 of 166 patients (16%) in the avacopan group and 23 of 164 patients (14%) in the prednisone group had a baseline eGFR ≤20 ml/min per 1.73 m2. At week 52, eGFR increased on average 16.1 and 7.7 ml/min per 1.73 m2 in the avacopan and prednisone groups, respectively (P = 0.003). The last eGFR value measured during the 52-week treatment period was ≥2-fold higher than baseline in 41% of patients in the avacopan group compared to 13% in the prednisone group (P = 0.030). More patients in the avacopan group versus prednisone group had increases in eGFR above 20, 30, and 45 ml/min per 1.73 m2, respectively. Serious adverse events occurred in 13 of 27 patients (48%) in the avacopan group and 16 of 23 patients (70%) in the prednisone group. Conclusion: Among patients with baseline eGFR ≤20 ml/min per 1.73 m2 in the ADVOCATE trial, eGFR improved more in the avacopan group than in the prednisone group.

Published
2023

15. Tolérance et efficacité des thérapies ciblées prescrites pour des indications hors AMM dans les maladies auto-immunes systémiques réfractaires : données des 187 premiers patients inclus dans le registre TATA (TArgeted Therapy in Autoimmune Diseases)

Author

Gottenberg, J.E., primary, Kane, B.S., additional, Allenbach, Y., additional, Mékinian, A., additional, Amoura, Z., additional, Cacoub, P., additional, Cornec, D., additional, Hachulla, E., additional, Quartier, P., additional, Richez, C., additional, Seror, R., additional, Terrier, B., additional, Pensec, V. Devauchelle, additional, Henry, J., additional, Gatfosse, M., additional, Bouillet, L., additional, Gaigneux, E., additional, André, V., additional, Saunier, A., additional, Desmurs, M., additional, Poulet, A., additional, Bienvenu, B., additional, Truchetet, M.E., additional, Michaud, M., additional, Larroche, C., additional, Dellal, A., additional, Leurs, A., additional, Ottaviani, S., additional, Nielly, H., additional, Vial, G., additional, Jaussaud, R., additional, Rouviere, B., additional, Jeandel, C., additional, Guffroy, A., additional, Jouvray, M., additional, Gramont, B., additional, Lavigne, C., additional, Marotte, H., additional, Moulinet, T., additional, Pers, Y., additional, Queyrel-Moranne, V., additional, Maalouf, G., additional, Bolko, L., additional, Rein, C., additional, Legendre, P., additional, Meyer, A., additional, Sibilia, J., additional, Yahia, S. Ahmed, additional, Kleinmann, J.F., additional, and Mariette, X., additional

Published
2023
Full Text
View/download PDF

16. Fréquence de découverte d’une artérite à cellules géantes asymptomatique ou d’une néoplasie sur la 18-FDG TEP-TDM chez les patients ayant une pseudo-polyarthrite rhizomélique isolée

Author

Le Madec, A., primary, Querellou, S., additional, Quéré, B., additional, Jousse Joulin, S., additional, Saraux, A., additional, Cornec, D., additional, Marhadour, T., additional, Tison, A., additional, Guellec, D., additional, and Devauchelle Pensec, V., additional

Published
2023
Full Text
View/download PDF

17. Abatacept dans la pseudopolyarthrite rhizomélique récente (ALORS) : essai randomisé versus placebo

Author

Saraux, A., primary, Le Henaff, C., additional, Dernis, E., additional, Carvajal Alegria, G., additional, Tison, A., additional, Quéré, B., additional, Petit, H., additional, Felten, R., additional, Jousse Joulin, S., additional, Guellec, D., additional, Marhadour, T., additional, Kervarrec, P., additional, Cornec, D., additional, Querellou, S., additional, Nowak, E., additional, Souki, A., additional, and Devauchelle Pensec, V., additional

Published
2023
Full Text
View/download PDF

18. Impact de la période de réévaluation par le PRAC sur l’initiation des inhibiteurs de JAK dans la polyarthrite rhumatoïde : données du registre MAJIK-SFR

Author

Avouac, J., primary, Hucteau, E., additional, Thevenot, P., additional, Carvajal Alegria, G., additional, Cornec, D., additional, Daien, C., additional, Dernis, E., additional, Fautrel, B., additional, Roux, C., additional, Salmon, J.H., additional, Sellam, J., additional, Bezin, J., additional, Prati, C., additional, and Truchetet, M.E., additional

Published
2023
Full Text
View/download PDF

20. Les anticorps anti-Ro52 pourraient être associés à une plus grande sévérité de la maladie chez les patients atteints de la maladie de Sjögren par l’activation de la voie de l’interféron

Author

Bettacchioli, E., primary, Saraux, A., additional, Tison, A., additional, Cornec, D., additional, Dueymes, M., additional, Foulquier, N., additional, Hillion, S., additional, Roguedas, A.M., additional, Benyoussef, A.A., additional, Precisesads, C.C., additional, Precisesads, S.C., additional, Alarcon-Riquelme, M.E., additional, Pers, J.O., additional, and Pensec, V. Devauchelle, additional

Published
2023
Full Text
View/download PDF

22. EP11.02-08 Predictive Toxicity and Response to Immunotherapy in Patients with Metastatic Non Small Cell Lung Cancer (IMMUNOPREDICT)

Author

Nguyen, J., primary, Quere, G., additional, Descourt, R., additional, Geier, M., additional, Babey, H., additional, Saliou, P., additional, Picard, J., additional, Dhamelincourt, E., additional, Fave, T., additional, Laune, Q., additional, Simaki, A., additional, Renaud, E., additional, and Cornec, D., additional

Published
2023
Full Text
View/download PDF

25. POS0969 PREDICTIVE FACTORS OF FAVOURABLE EVOLUTION IN GLUCOCORTICOIDS-DEPENDENT POLYMYALGIA RHEUMATICA

Author

Boukhlal, S., primary, Aghiles, S., additional, Emmanuel, N., additional, Carvajal Alegria, G., additional, Dernis, E., additional, Richez, C., additional, Direz, G., additional, Chary Valckenaere, I., additional, Truchetet, M. E., additional, Wendling, D., additional, Toussirot, E., additional, Perdriger, A., additional, Gottenberg, J. E., additional, Felten, R., additional, Fautrel, B., additional, Chiche, L., additional, Hilliquin, P., additional, Le Henaff Bourhis, C., additional, Benjamin, D., additional, Lohse, A., additional, Guellec, D., additional, Marhadour, T., additional, Pochard, P., additional, Cornec, D., additional, Saraux, A., additional, and Devauchelle-Pensec, V., additional

Published
2023
Full Text
View/download PDF

27. POS1454 ARE ULTRASOUND SALIVARY PARENCHYMAL ABNORMALITIES MORE SEVERE IN PRIMARY SJÖGREN PATIENTS WITH A HIGHER DISEASE DURATION? A TRANSVERSAL INTERNATIONAL STUDY

Author

Tison, A., primary, Jousse-Joulin, S., additional, Consigny, M., additional, Moog, P., additional, Hofauer, B., additional, Hachulla, E., additional, Lamotte, C., additional, Morel, J., additional, Mouterde, G., additional, Milic, V., additional, Bootsma, H., additional, Stel, A. J., additional, Fisher, B. A., additional, Maybury, M., additional, Baer, A., additional, Direnzo, D., additional, Kim, H. R., additional, Min, H. K., additional, Lee, S. S., additional, Choi, S. E., additional, Carvajal Alegria, G., additional, Boisramé, S., additional, Guellec, D., additional, Cornec, D., additional, Jonsson, M., additional, Hammenfors, D., additional, Saraux, A., additional, and Devauchelle-Pensec, V., additional

Published
2023
Full Text
View/download PDF

30. OP0210 BRUTON’S TYROSINE KINASE (BTK) IS A NOVEL INDEPENDENT BIOMARKER OF LYMPHOMA IN PRIMARY SJÖGREN’S SYNDROME: DATA FROM 346 PATIENTS OF THE ASSESS COHORT

Author

Duret, P. M., primary, Schleiss, C., additional, Sedmak, N., additional, Meyer, N., additional, Ye, T., additional, Kawka, L., additional, Saraux, A., additional, Devauchelle-Pensec, V., additional, Cornec, D., additional, Larroche, C., additional, Perdriger, A., additional, Seror, R., additional, Felten, R., additional, Sibilia, J., additional, Nocturne, G., additional, Mariette, X., additional, and Gottenberg, J. E., additional

Published
2023
Full Text
View/download PDF

31. OP0217 ANTI-RO52 ANTIBODIES ARE ASSOCIATED WITH HIGHER DISEASE SEVERITY IN PATIENTS WITH SJÖGREN DISEASE THROUGH ACTIVATION OF THE INTERFERON PATHWAY

Author

Bettacchioli, E., primary, Saraux, A., additional, Tison, A., additional, Cornec, D., additional, Dueymes, M., additional, Foulquier, N., additional, Hillion, S., additional, Roguedas-Contios, A. M., additional, Benyoussef, A. A., additional, Alarcon-Riquelme, M., additional, Pers, J. O., additional, and Devauchelle-Pensec, V., additional

Published
2023
Full Text
View/download PDF

32. POS0718 IS IT POSSIBLE TO EVALUATE POLYMYALGIA RHEUMATICA WITHOUT CRP? CONCORDANCE AND AGREEMENT BETWEEN DIFFERENT PMR-AS ACTIVITY SCORES IN POLYMYALGIA RHEUMATICA

Author

Justine, D., primary, Aghiles, S., additional, Lohse, A., additional, Carvajal Alegria, G., additional, Dernis, E., additional, Richez, C., additional, Truchetet, M. E., additional, Wendling, D., additional, Toussirot, E., additional, Perdriger, A., additional, Gottenberg, J. E., additional, Fautrel, B., additional, Chiche, L., additional, Hilliquin, P., additional, Le Henaff Bourhis, C., additional, Benjamin, D., additional, Direz, G., additional, Chary Valckenaere, I., additional, Cornec, D., additional, Guellec, D., additional, Marhadour, T., additional, Emmanuel, N., additional, Saraux, A., additional, and Devauchelle-Pensec, V., additional

Published
2023
Full Text
View/download PDF

34. POS1445 INCLUSION BODY MYOSITIS ASSOCIATED WITH SJÖGREN SYNDROME HAS DIFFERENT IMMUNE CELLS INFILTRATE FROM SPORADIC INCLUSION BODY MYOSITIS

Author

Quéré, B., primary, Bourhis, A., additional, Hémon, P., additional, Pers, J. O., additional, Noury, J. B., additional, Marcorelles, P., additional, Guellec, D., additional, Allenbach, Y., additional, Marianpillai, K., additional, Léonard-Louis, S., additional, Sanges, S., additional, Maurage, C. A., additional, Nocturne, G., additional, Adam, C., additional, Meyer, A., additional, Lannes, B., additional, Urbanski, G., additional, Croue, A., additional, Devauchelle-Pensec, V., additional, Uguen, A., additional, and Cornec, D., additional

Published
2023
Full Text
View/download PDF

36. Le tocilizumbab améliore les perturbations de l’immunité innée au cours des pseudo-polyarthrites rhizoméliques dépendantes des corticoïdes

Author

Carvajal Alegria, G., primary, Boukhlal, S., additional, Hillion, S., additional, Pochard, P., additional, Porchet, E., additional, Saraux, A., additional, Jousse Joulin, S., additional, Marhadour, T., additional, Guellec, D., additional, Cornec, D., additional, and Devauchelle Pensec, V., additional

Published
2022
Full Text
View/download PDF

37. Lésions sternales et vertébrales menaçantes en lien avec une maladie de Gorham-Stout : une évolution spectaculaire sous évérolimus !

Author

Boyard, A., primary, Stephant, M., additional, Berthelot, J.M., additional, Canaud, G., additional, Confavreux, C., additional, Cornec-Le Gall, E., additional, Mercier, O., additional, Quehe, P., additional, Saraux, A., additional, Jousse Joulin, S., additional, Cornec, D., additional, Guellec, D., additional, Tison, A., additional, Devauchelle Pensec, V., additional, and Marhadour, T., additional

Published
2022
Full Text
View/download PDF

38. Efficacité du Tocilizumab chez les patients ayant une Pseudo Polyarthrite Rhizomélique active malgré un traitement par corticothérapie : une étude thérapeutique randomisée

Author

Devauchelle Pensec, V., primary, Carvajal Alegria, G., additional, Dernis, E., additional, Richez, C., additional, Truchetet, M.E., additional, Wendling, D., additional, Toussirot, É., additional, Perdriger, A., additional, Gottenberg, J.E., additional, Felten, R., additional, Fautrel, B., additional, Chiche, L., additional, Hilliquin, P., additional, Le Henaff, C., additional, Dervieux, B., additional, Direz, G., additional, Chary Valckenaere, I., additional, Cornec, D., additional, Guellec, D., additional, Marhadour, T., additional, Nowak, E., additional, and Saraux, A., additional

Published
2022
Full Text
View/download PDF

39. Est-il possible d’évaluer la pseudopolyarthrite rhizomélique sans CRP ? Concordance et corrélation entre différents scores d’activité DAS-PPR dans la pseudopolyarthrite rhizomélique

Author

D’agostino, J., primary, Saraux, A., additional, Carvajal Alegria, G., additional, Dernis, E., additional, Richez, C., additional, Truchetet, M.E., additional, Wendling, D., additional, Toussirot, É., additional, Perdriger, A., additional, Gottenberg, J.E., additional, Felten, R., additional, Fautrel, B., additional, Chiche, L., additional, Hilliquin, P., additional, Le Henaff, C., additional, Dervieux, B., additional, Direz, G., additional, Chary-Valckenaere, I., additional, Cornec, D., additional, Guellec, D., additional, Marhadour, T., additional, Souki, A., additional, Nowak, E., additional, and Devauchelle Pensec, V., additional

Published
2022
Full Text
View/download PDF

40. Performance du nouveau critère de réponse du syndrome de Sjögren primitif (SSp), le STAR (Sjögren's tool for assessing response) : réanalyse de 9 essais cliniques dans le SSp

Author

Seror, R., primary, Baron, G., additional, Cornec, D., additional, Perrodeau, E., additional, Camus, M., additional, Bowman, S., additional, Bombardieri, M., additional, Bootsma, H., additional, Arends, S., additional, Gottenberg, J.E., additional, Fisher, B., additional, Hueber, W., additional, Van Roon, J., additional, Devauchelle Pensec, V., additional, De Wolff, L., additional, Gergely, P., additional, Mariette, X., additional, and Porcher, R., additional

Published
2022
Full Text
View/download PDF

42. La surexpression de la tyrosine kinase de Bruton (BTK) est un facteur de risque indépendant de lymphome compliquant le syndrome de Sjögren primaire : données de 346 patients de la cohorte de la SFR ASSESS

Author

Duret, P.M., primary, Schleiss, C., additional, Sedmak, N., additional, Meyer, N., additional, Ye, T., additional, Kawka, L., additional, Saraux, A., additional, Devauchelle Pensec, V., additional, Cornec, D., additional, Larroche, C., additional, Perdriger, A., additional, Seror, R., additional, Felten, R., additional, Sibilia, J., additional, Nocturne, G., additional, Mariette, X., additional, and Gottenberg, J.E., additional

Published
2022
Full Text
View/download PDF

43. Facteurs prédictifs d’évolution favorable de la pseudo-polyarthrite rhizomélique corticodépendante

Author

Boukhlal, S., primary, Souki, A., additional, Nowak, E., additional, Carvajal Alegria, G., additional, Dernis, E., additional, Richez, C., additional, Direz, G., additional, Chary Valckenaere, I., additional, Truchetet, M.E., additional, Wendling, D., additional, Toussirot, É., additional, Perdriger, A., additional, Gottenberg, J.E., additional, Felten, R., additional, Fautrel, B., additional, Chiche, L., additional, Hilliquin, P., additional, Le Henaff, C., additional, Dervieux, B., additional, Guellec, D., additional, Marhadour, T., additional, Cornec, D., additional, Saraux, A., additional, and Devauchelle Pensec, V., additional

Published
2022
Full Text
View/download PDF

47. OP0286 DEVELOPMENT AND PRELIMINARY VALIDATION OF THE SJÖGREN’S TOOL FOR ASSESSING RESPONSE (STAR): A CONSENSUAL COMPOSITE SCORE FOR ASSESSING TREATMENT EFFECT IN PRIMARY SJÖGREN’S SYNDROME

Author

Seror, R., primary, Baron, G., additional, Camus, M., additional, Cornec, D., additional, Perrodeau, E., additional, Bowman, S. J., additional, Bombardieri, M., additional, Bootsma, H., additional, Gottenberg, J. E., additional, Fisher, B., additional, Hueber, W., additional, van Roon, J., additional, Devauchelle-Pensec, V., additional, Gergely, P., additional, Mariette, X., additional, and Porcher, R., additional

Published
2022
Full Text
View/download PDF

48. AB1531-HPR ECOLOGICAL MOMENTARY ASSESSMENT OF THE SYMPTOMS IN SJÖGREN’S SYNDROME: DEVELOPMENT AND VALIDATION OF A DEDICATED WebApp

Author

Laurie, G., primary, Berrouiguet, S., additional, Benyoussef, A. A., additional, Guellec, D., additional, Carvajal, G., additional, Marhadour, T., additional, Jousse-Joulin, S., additional, Cochener-Lamard, B., additional, Labetoulle, M., additional, Gottenberg, J. E., additional, Bourcier, T., additional, Saraux, A., additional, Consigny, M., additional, Gravey, M., additional, Devauchelle-Pensec, V., additional, Seror, R., additional, and Cornec, D., additional

Published
2022
Full Text
View/download PDF

50. AB1462 RHEUMATIC IMMUNE- AND NONIMMUNE-RELATED ADVERSE EVENTS IN PHASE 3 CLINICAL TRIALS ASSESSING PD-(L)1 CHECKPOINT INHIBITORS FOR LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS

Author

Veccia, A., primary, Kostine, M., additional, Tison, A., additional, Dipasquale, M., additional, Kingspergher, S., additional, Grandi, G., additional, Caffo, O., additional, Inchiostro, S., additional, Paolazzi, G., additional, Bortolotti, R., additional, Cornec, D., additional, and Berti, A., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results